- Home
- OCGN vs FOA Comparison
OCGN vs FOA Comparison
Compare OCGN & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- FOA
- Stock Information
- Founded
- OCGN 2013
- FOA 2013
- Country
- OCGN United States
- FOA United States
- Employees
- OCGN N/A
- FOA N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- FOA Finance Companies
- Sector
- OCGN Health Care
- FOA Finance
- Exchange
- OCGN Nasdaq
- FOA Nasdaq
- Market Cap
- OCGN 321.7M
- FOA 284.3M
- IPO Year
- OCGN N/A
- FOA N/A
- Fundamental
- Price
- OCGN $1.39
- FOA $25.13
- Analyst Decision
- OCGN Strong Buy
- FOA Buy
- Analyst Count
- OCGN 3
- FOA 2
- Target Price
- OCGN $6.00
- FOA $27.50
- AVG Volume (30 Days)
- OCGN 2.6M
- FOA 114.8K
- Earning Date
- OCGN 11-07-2025
- FOA 11-05-2025
- Dividend Yield
- OCGN N/A
- FOA N/A
- EPS Growth
- OCGN N/A
- FOA N/A
- EPS
- OCGN N/A
- FOA 7.10
- Revenue
- OCGN $4,754,000.00
- FOA $527,520,999.00
- Revenue This Year
- OCGN N/A
- FOA $21.89
- Revenue Next Year
- OCGN N/A
- FOA $10.33
- P/E Ratio
- OCGN N/A
- FOA $3.42
- Revenue Growth
- OCGN N/A
- FOA 46.94
- 52 Week Low
- OCGN $0.52
- FOA $10.00
- 52 Week High
- OCGN $1.33
- FOA $32.40
- Technical
- Relative Strength Index (RSI)
- OCGN 83.73
- FOA 46.70
- Support Level
- OCGN $1.00
- FOA $24.42
- Resistance Level
- OCGN $1.25
- FOA $26.05
- Average True Range (ATR)
- OCGN 0.06
- FOA 1.37
- MACD
- OCGN 0.04
- FOA -0.33
- Stochastic Oscillator
- OCGN 92.69
- FOA 21.39
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.